TOLULOPE OGUNTOMI: Open Payments
NPI 1881221265 · LA PLATA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 18 payments from 5 companies in 2025. Trend: 2023 $75 · 2024 $159 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $365 |
| Otsuka America Pharmaceutical, Inc. | 4 | $75 |
| Lundbeck LLC | 3 | $74 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| TMS NeuroHealth Centers Inc. | 1 | $26 |
Products named: VRAYLAR, REXULTI, UZEDY, TMS NeuroHealth Centers Inc., ABILIFY ASIMTUFII.
Industry payments across MD — which companies pay providers there.
